Weekly shot tested to fight obesity and diabetes
NCT ID NCT06567041
Summary
This early-stage study tested a new weekly injection called NNC0519-0130 in adults with obesity or type 2 diabetes. Researchers wanted to see if it was safe, how it worked in the body, and if it could help with weight loss and blood sugar control. Participants were randomly assigned to receive either the real injection or a placebo (dummy shot) for about 8-9 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Parexel International GmbH
Berlin, 14050, Germany
Conditions
Explore the condition pages connected to this study.